Trends in the Management of Headache Disorders in US Emergency Departments: Analysis of 2007–2018 National Hospital Ambulatory Medical Care Survey Data

Abstract

We examined trends in management of headache disorders in United States (US) emergency department (ED) visits. We conducted a cross-sectional study using 2007–2018 National Hospital Ambulatory Medical Care Survey data. We included adult patient visits (≥18 years) with a primary ED discharge diagnosis of headache. We classified headache medications by pharmacological group: opioids, butalbital, ergot alkaloids/triptans, acetaminophen/nonsteroidal anti-inflammatory drugs (NSAIDs), antiemetics, diphenhydramine, corticosteroids, and intravenous fluids. To obtain reliable estimates, we aggregated data into three time periods: 2007–2010, 2011–2014, and 2015–2018. Using multivariable logistic regression, we examined medication, neuroimaging, and outpatient referral trends, separately. Among headache-related ED visits, opioid use decreased from 54.1% in 2007–2010 to 28.3% in 2015–2018 (Ptrend < 0.001). There were statistically significant increasing trends in acetaminophen/NSAIDs, diphenhydramine, and corticosteroids use (all Ptrend < 0.001). Changes in butalbital (6.4%), ergot alkaloid/triptan (4.7%), antiemetic (59.2% in 2015–2018), and neuroimaging (37.3%) use over time were insignificant. Headache-related ED visits with outpatient referral for follow-up increased slightly from 73.3% in 2007–2010 to 79.7% in 2015–2018 (Ptrend = 0.02). Reflecting evidence-based guideline recommendations for headache management, opioid use substantially decreased from 2007 to 2018 among US headache-related ED visits. Future studies are warranted to identify strategies to promote evidence-based treatment for headaches (e.g., sumatriptan, dexamethasone) and appropriate outpatient referral and reduce unnecessary neuroimaging orders in EDs.

Risk of Migraine after Traumatic Brain Injury and Effects of Injury Management Levels and Treatment Modalities: A Nationwide Population-Based Cohort Study in Taiwan

“…Moreover, managing socioeconomic and family-related stressors plays a crucial role in managing the effects of persistent PCS [ 49 , 59 ]. Furthermore, pharmacological treatment [ 60 ], such as acute or preventive medications for primary headache disorders, is useful [ 19 , 25 , 61 ].…”

“…Following this, some of the most severe TBI patients can survive with impaired neurological function [ 23 ]. Moreover, because of the long-term effects of TBI, early follow-up and further rehabilitation are essential to facilitate recovery [ 24 , 25 ].…”

Characterizing opioid use in a Dutch cohort with migraine

“…In addition, our study shows that opioids are prescribed mostly as treatment for acute migraine attacks, by a variety of physicians and also in an emergency setting where migraine subjects seek acute help for their headaches. Previous studies have concluded that prescribing opioids for migraine attacks in an emergency setting in the United States is common (25). While a cross-sectional study in the US showed that opioid use decreased from 2007 to 2018 among headache-related ER visits, it is still high (up to 28%) (25).…”

GAHBT: Genetic Based Hashing Algorithm for Managing and Validating Health Data Integrity in Blockchain Technology

“…Similarly, we gradually increase the number of hospitals by keeping the number of records constant, based on 4,000. 36 All the simulations have been done on the MATLAB simulator.…”